TP53 and breast cancer: For example, El-Masry et al. (2012) and Liu et al. (2015) both used multiple breast cancer cell lines with diverse genetic backgrounds (i.e. varying p53 and estrogen receptor statuses) to reveal the phenotypic effects of phenformin on different subtypes of breast cancer [16, 34].